Glutathione supplement warning for firefighters
Analysis based on 12 articles · First reported Aug 23, 2026 · Last updated Aug 24, 2026
The advisory may reduce demand for glutathione treatments among firefighters, potentially affecting compounding pharmacies and supplement providers. However, the event is unlikely to have significant market-wide impact, given the niche nature of the product and the absence of major publicly traded companies directly involved.
Fire and medical officials issued warnings about the supplement glutathione offered to Western wildland firefighters exposed to toxic chemicals during major wildfires. Glutathione, administered via IV or nebulizer, has not been proven safe or effective and may cause illness if contaminated. At least two pharmacies recalled the supplement in August due to bacterial contamination, with reports of fever, chills, and severe headache. The International Association of Fire Fighters issued a safety advisory, noting glutathione is not FDA-approved. The supplement was offered during recent United States — Spokane, Washington wildfires by the Integrative Health Action Network, a naturopathic group that previously provided it during the January 2025 United States — Los Angeles County, California wildfires. Some firefighters reported feeling better, but others became sick. Experts, including Dr. Cora Sack and Luke Montrose, emphasized the lack of clinical evidence and potential risks. The United States — California State Board of Pharmacy reversed regulations that would have restricted access after pushback from firefighters.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard